Authors


Jay S. Duker, MD

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability


Nadia K. Waheed, MD, MPH

Latest:

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

Study aims to identify methodology for least amount of variation, greatest test-retest reliability




Christine N. Kay, MD

Latest:

CTS 2025: Christine Kay, MD, on OPGx-LCA5 clinical results translated into real-life changes

Phase 1/2 interim results highlight real-world functional enhancements in patients with severe LCA5-related Leber congenital amaurosis.



Netan Choudhry, MD

Latest:

The subthreshold laser’s role in retinal vascular disease

Combination therapy benefits from laser in the mix for DME, other conditions


Munir Escaf, MD

Latest:

Laser therapy may offer fast-acting option for CSR resolution

Patients tolerate therapy well; high safety profile allows re-treatment as necessary


Alex Delaney-Gesing

Latest:

Update on FDA approval of XIPERE for macular edema associated with uveitis from Bausch + Lomb

Bausch + Lomb's Yolande Barnard shares an update on the FDA approval of XIPERE for the treatment of macular edema associated with uveitis.


OT Staff Reports

Latest:

Comparing suitable naïve versus pre-treated DME patients

Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.


Rishi P. Singh, MD

Latest:

ARVO 2025: Rishi Singh, MD, discusses real-world clinical outcomes in patients with DME

In an analysis of the IRIS database, investigators assessed almost 1,200 eyes that had been treated with faricimab.


Nimesh A. Patel, MD

Latest:

FISH in focus for fast eye infection diagnosis

Despite cost, advantages include sensitivity, improved outcomes



Pauline T. Merrill, MD

Latest:

ST laser therapy may reduce DME intravitreal injections

Used as an adjunct, ST laser therapy may reduce the treatment burden for patients while maintaining visual acuity.




© 2025 MJH Life Sciences

All rights reserved.